Journal of lower genital tract disease (J Low Genit Tract Dis)

Journal PubWeight™ 505.89‹?›

Top papers

Rank Title Year PubWeight™‹?›
1 Evaluation of a cervicography-based program to ensure quality of visual inspection of the cervix in HIV-infected women in Johannesburg, South Africa. 2015 3.30
2 The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. 2012 3.19
3 American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. 2012 3.15
4 2006 consensus guidelines for the management of women with abnormal cervical screening tests. 2007 3.11
5 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. 2013 3.06
6 Use of CO2 laser vaporization for the treatment of high-grade vaginal intraepithelial neoplasia. 2013 2.63
7 Human papillomavirus vaccine acceptability among parents of 10- to 15-year-old adolescents. 2004 2.24
8 Associations between religion-related factors and cervical cancer screening among Muslims in greater chicago. 2014 2.18
9 Benchmarking CIN 3+ risk as the basis for incorporating HPV and Pap cotesting into cervical screening and management guidelines. 2013 2.18
10 Vulvar seborrheic keratosis: is there a relationship to human papillomavirus? 2014 2.14
11 Detection rates of trichomonas vaginalis, in different age groups, using real-time polymerase chain reaction. 2012 2.11
12 Practice improvement in cervical screening and management (PICSM): symposium on management of cervical abnormalities in adolescents and young women. 2010 2.03
13 Quantification of normal vaginal constituents using a new wet preparation technique. 2012 2.02
14 Vulvovaginal candidiasis as a chronic disease: diagnostic criteria and definition. 2014 2.01
15 Utility of microscopic techniques and quantitative real-time polymerase chain reaction for the diagnosis of vaginal microflora alterations. 2015 1.99
16 eC3--a modern telecommunications matrix for cervical cancer prevention in Zambia. 2010 1.98
17 A clinicopathologic study of labia minora hypertrophy: signs of localized lymphedema were universal. 2014 1.98
18 Cervical cancer screening among immigrants and ethnic minorities: a systematic review using the Health Belief Model. 2008 1.92
19 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. 2007 1.90
20 Evaluation of the VITOM in digital high-definition video exocolposcopy. 2011 1.87
21 Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance. 2015 1.73
22 Knowledge and attitudes of adult peruvian women vis-à-vis Human Papillomavirus (HPV), cervical cancer, and the HPV vaccine. 2010 1.59
23 The vulvodynia guideline. 2005 1.55
24 A Randomized Trial of Human Papillomavirus Self-Sampling as an Intervention to Promote Cervical Cancer Screening Among Women With HIV. 2016 1.54
25 Review of terminology of precursors of vulvar squamous cell carcinoma. 2006 1.52
26 Spectroscopic imaging as a triage test for cervical disease: a prospective multicenter clinical trial. 2007 1.52
27 Comparison of conventional cervical cytology versus visual inspection with acetic acid among human immunodeficiency virus-infected women in Western Kenya. 2012 1.50
28 Clinical performance characteristics of the Cervista HPV HR test kit in cervical cancer screening in China. 2012 1.47
29 Management of vulvovaginal lichen planus: a new approach. 2013 1.45
30 Cytological evaluation correlates poorly with histological diagnosis of vulvar neoplasias. 2007 1.43
31 Communicating colposcopy results: what do patients and providers discuss? 2008 1.42
32 Evaluation of a low-cost liquid-based Pap test in rural El Salvador: a split-sample study. 2014 1.40
33 Endometrial cells in pap smears of postmenopausal women: cytohistologic correlation. 2003 1.40
34 Selecting Patients for Endocervical Curettage. 2015 1.40
35 Vulvar lichen sclerosus: a comparison of the short-term topical application of clobetasol dipropionate 0.05% versus mometasone furoate 0.1%. 2015 1.40
36 The Value of Endocervical Curettage in Addition to Biopsies in Women Referred to Colposcopy. 2015 1.39
37 Human papillomavirus vaccination: the policy debate over the prevention of cervical cancer--a commentary. 2008 1.38
38 Outcomes after treatment of cervical intraepithelial neoplasia among women with HIV. 2007 1.37
39 Umbilication is a strong predictor of high-grade cervical intraepithelial neoplasia. 2013 1.37
40 Five-year risks of CIN 3+ and cervical cancer among women who test Pap-negative but are HPV-positive. 2013 1.36
41 Which Colposcopies Should Include Endocervical Curettage? 2015 1.36
42 Prevalence of recurrent vulvovaginal candidiasis in 5 European countries and the United States: results from an internet panel survey. 2013 1.30
43 Aggressive angiomyxoma of the vulva: a case report and review of the literature. 2009 1.29
44 The accuracy of colposcopic grading for detection of high-grade cervical intraepithelial neoplasia. 2009 1.28
45 Five-year risks of CIN 3+ and cervical cancer among women with HPV testing of ASC-US Pap results. 2013 1.27
46 Use of Smartphones as Adjuvant Tools for Cervical Cancer Screening in Low-Resource Settings. 2015 1.27
47 Prevalence of human papillomavirus types in invasive vulvar cancers and vulvar intraepithelial neoplasia 3 in the United States before vaccine introduction. 2012 1.26
48 Pain at the vulvar vestibule: a web-based survey. 2004 1.25
49 Risk assessment to guide the prevention of cervical cancer. 2008 1.21
50 Five-year risks of CIN 2+ and CIN 3+ among women with HPV-positive and HPV-negative LSIL Pap results. 2013 1.20
Next 50